Skip to main content

Table 3 EVs are an emerging class diagnostic markers for TBI and associated complicationsa

From: Roles and therapeutic potential of different extracellular vesicle subtypes on traumatic brain injury

EV Sources: Cell type/Tissue/species

Method of measurement

Tested components of EV

Sampling time point

Main findings

Ref

Endothelial, platelet, and leukocyte/plasma/human

Flow cytometry

•TF

•P-selection

6,12,24,48 and 72 h post-injury

MP counts in cerebral vein samples, regardless of cell origin, were higher in TBI cases compared with healthy groups; and MP counts decreased sharply from high levels shortly after TBI to slightly higher levels 72 h later

M.Nekludov et al. [54]

EV in circulating blood /Plasma/human

Paramagnetic bead-based enzyme-linked immunosorbent assay

Protein quantification

years post injury

The levels of plasma EV and NfL were significantly increased in patients with repeated mild TBI; Even years after injury, the increase was greatest in patients with chronic post-concussive syndrome, post-traumatic stress disorder, and depression symptoms

Guedes VA et al. [171]

BDEVs/plasm/mouse and human

•RNA sequencing

•Machine learning algorithms

miRNA

1 h after single or multiple injuries, 0.4–120 h after injury(clinical samples)

Machine learning algorithms processing miRNAs in brain-derived EVs can detect various injury types and characteristics of TBI, reflecting the heterogeneity of human TBI injury and recovery more accurately than traditional diagnosis

Ko J et al. [172]

EV in circulating blood /plasm/human

•ELISA

•RNA Sequencing

•GFAP

•Short noncoding RNA

—

Increased GFAP concentrations in EVs from TBI patients with altered consciousness, as well as differential expression of multiple miRNAs targeting TBI-related pathways, suggest that EVs may be potential carriers of TBI biomarkers

Puffer RC et al. [173]

Astrocytes/culture medium/ human

Droplet digital PCR

specific

subset of miRNAs

24 h post-IL-1β induced inflammatory stress

Astrocyte-derived EVs express a specific subset of miRNA that may play a potential role in modulating inflammatory responses

Manoshi Gayen et al. [34]

Neurons/ brain/ Mouse

RNA sequencing

miR-21

1–7 days post- injury

As a potential neuron-derived EV cargo, miR-21 may mediate the activation of microglia

Harrison EB et al. [35]

Brain endothelial cells/ plasma/Mouse

•Flow Cytometry

•Electron microscopy

Tight junction proteins

24 h post-injury

•Brain endothelial cells release eEVs containing TJP and endothelial markers to mediate vascular remodeling after TBI

•Detection of brain endothelial-derived EVs provides a novel approach to assess BBB structure and function in trauma and neuroinflammation

Andrews AM et al. [38]

Neurons and glial cells/ brain, plasma/Mouse

•Flow Cytometry

•Electron microscopy

PS and TF on membrane

0.5,1,3 and 6 h post-injury

•The traumatized brain releases procoagulant BDMPs into the circulation to trigger a disseminated coagulation cascade

•The abundance of PS and TF on the membrane surface is responsible for the procoagulant activity of BDMPs

Ye Tian et al. [23]

Neurons and glial cells/ plasma/ Mouse

•Flow Cytometry

•Electron microscopy

CL on mitochondrial membrane

0.25, 0.5,1,3,7,10,14 days post-injury

•The mtMP is a major subset of BDEVs

•Abundant CL on the membrane surface is responsible for mtMPs-triggered coagulation dysfunction after TBI

Zilong Zhao et al. [24]

EV in circulating blood /plasma/human

RNA sequencing

Specific mRNA and lncRNA

—

Analysis of SEV and LEV cargoes suggests that RNA may serve as novel, readily accessible biomarkers for AD, PD, ALS, and FTD in the future

Sproviero et al. D [47]

  1. aAbbreviations AD Alzheimer's disease, ALS amyotrophic lateral sclerosis, BBB blood–brain barrier, BDEV brain-derived extracellular vesicles, BDMPs brain-derived microparticles, CL cardiolipin, eEVs endothelial-derived extracellular vesicles, ELISA enzyme-linked immunosorbent assay, EVs extracellular vesicles, FTD frontotemporal dementia GFAP glial fibrillary acidic protein, LEV large extracellular vesicles, MP microparticles, NfL neurofilament light, PCR polymerase chain reaction, PD Parkinson's disease, PS phosphatidylserine, SEV small extracellular vesicles, TBI traumatic brain injury, TF tissue factor, TJP tight junction proteins